Latest News and Press Releases
Want to stay updated on the latest news?
-
GENFIT today announced the appointment of Dr. Pejvack Motlagh, the new Chief Medical Officer of GENFIT
-
GENFIT annonce aujourd’hui la nomination du Dr. Pejvack Motlagh en tant que nouveau Directeur Médical de GENFIT.
-
AMX-883 shows synergistic efficacy in combination with venetoclax in vivo and prevents the emergence of resistance to venetoclax in vitro, addressing a major clinical challenge in acute myeloid...
-
November 20, 2025 21:16 ET | Source: Talal A. Debs, Founder and Concerned Shareholder of Zefiro Methane Corp.
Zefiro’s largest shareholder calls for change to replace self-serving and conflicted board that is destroying shareholder value
-
EVerZom’s investigational drug candidate EViv, developed to treat ACLF, using its proprietary exosome platform, represents a novel approach to regenerative therapies Pending successful in vivo...
-
Le candidat-médicament expérimental EViv d'EVerZom, développé pour le traitement de l'ACLF en utilisant sa plateforme propriétaire d'exosomes, représente une approche novatrice en matière de thérapies...
-
-- New preclinical data for PM577 in Wilson’s Disease (WD) to be presented at AASLD; on-track to file IND and/or CTA in H1’26, with initial clinical data expected in 2027 -- -- Nominated PM647 as...
-
-- New preclinical data for PM577 in Wilson’s Disease (WD) to be presented at AASLD; on-track to file IND and/or CTA in H1’26, with initial clinical data expected in 2027 -- -- Nominated PM647 as...
-
Continued focused execution of RLY-2608 clinical trials in PI3Kα-mutated breast cancer and vascular malformations Appointed Lonnel Coats and Habib Dable, former biotech CEOs with launch and...
-
― Pociredir Phase 1b PIONEER Trial Data in Sickle Cell Disease to be Presented and Published, Including 12 mg and 20 mg Cohorts ― ― Live and Webcast Investor Event with Fulcrum Leadership and Medical...